•
Jun 30, 2013

Cocrystal Pharma Q2 2013 Earnings Report

Total Revenue
$1.96M
Previous year: $4.91M
-60.2%
EPS
-$0.02
Previous year: -$0.01
+100.0%
Gross Profit
$552K
Previous year: $2.03M
-72.8%
Cash and Equivalents
$2.79M
Previous year: $174K
+1502.6%
Free Cash Flow
-$983K
Total Assets
$8.04M
Previous year: $9.07M
-11.4%

Cocrystal Pharma

Cocrystal Pharma